来自Solexa1月的消息，Illumina公司将以6亿美元左右的价钱，换股方式收购Solexa Inc. 生物通报道：来自Solexa1月的消息，Illumina公司将以6亿美元左右的价钱，换股方式收购Solexa Inc. 根据协议，Solexa的股东每股股票可获得价值14美元的Illumina的普通股，收购总额为6亿美元。

Illumina, Inc. and Solexa, Inc. have announced that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger ...

【MarketWatch伦敦11月13日讯】Illumina Inc. (ILMN)表示，同意透过换股方式收购Solexa Inc. (SLXA)。双方董事会均全体通过了这项收购。 根据协议，Solexa的股东每股股票可获得价值14美元的Illumina的普通股，收购总额为6亿美元。 Illumina还同意将投资5000万美元来换取新发行的 ...

Illumina公司（纳斯达克代码：ILMN）近日宣布，它首次对一个公开姓名的家庭进行了DNA测序。这个家庭共有4名成员，分别为John、Judy、Anne和Paul West。该项服务是在Illumina经CLIA认证的实验室中完成的，利用了Illumina的Genome Analyzer平台。 Illumina公司（纳斯达克代码：ILMN ...

Genome sequencing company Illumina Inc ILMN has transformed its business over the years with a handful of acquisitions and new product launches. An acquisition in 2006 was one of the most important in ...

Illumina Inc. said Monday it will buy Solexa Inc. for about $600 million. San Diego-based Illumina (NASDAQ:ILMN) is offering about $14 a share in its stock for every share of Hayward-based Solexa ...

Illumina Inc. said Monday it will buy Solexa Inc. for about $600 million. San Diego-based Illumina (NASDAQ: ILMN) is offering about $14 a share in its stock for every share of Hayward-based Solexa ...

Shares in Hayward biotech company Solexa Inc. jumped almost 30 percent after it announced a $600 million stock-for-stock merger agreement Monday with Illumina Inc. of San Diego, another maker of ...

for $14 a share, or $600 million in stock, in a merger of genetic science players. The deal gives holders of Hayward, Calif.-based Solexa a 45% premium to Friday's closing price. San Diego-based ...

Illumina, Inc. (Nasdaq:ILMN) today announced that, together with Solexa its wholly owned subsidiary, it has filed its initial response to the lawsuit brought by Life Technologies and Applied ...

NEW YORK (Reuters) - Gene-testing technology company Illumina Inc. will acquire Solexa Inc. in a stock deal valuing the developer of genetic analysis systems at about $600 million, the companies said ...